The Adherence eValuation After Ischemic Stroke Longitudinal (AVAIL) Registry: Design, rationale, and baseline patient characteristics Cheryl Bushnell,

Slides:

Advertisements

Similar presentations

Positioning Considerations in Robotic Surgery Christina Hortman, BSN, RN, Simon Chung, MD, MPH, MBA, FACS AORN Journal Volume 102, Issue 4, Pages

Advertisements

Chronic Lyme Disease: A Survey of Connecticut Primary Care Physicians Michael Johnson, MD, Henry M. Feder, MD The Journal of Pediatrics Volume 157, Issue.

Validity of the LaFarge equation for estimation of oxygen consumption in ventilated children with congenital heart disease younger than 3 years—A revisit.

High-dose Intravenous Immunoglobulin Therapy for Systemic Capillary Leak Syndrome (Clarkson Disease) Zhihui Xie, PhD, Eunice C. Chan, PhD, Lauren M. Long,

Joann R. Petrini, PhD, MPH, Todd Dias, MS, Marie C

Rationale, design, and baseline characteristics of the Canagliflozin Cardiovascular Assessment Study (CANVAS)—A randomized placebo-controlled trial Bruce.

Prevalence, characteristics, and predictors of early termination of cardiovascular clinical trials due to low recruitment: Insights from the ClinicalTrials.gov.

Effects of β-erythropoietin treatment on left ventricular remodeling, systolic function, and B-type natriuretic peptide levels in patients with the cardiorenal.

Arif H. Kamal, MD, MBA, MHS, Janet H. Bull, MD, MBA, Keith M

Atrial fibrillation and quality of life after pacemaker implantation for sick sinus syndrome: Data from the Mode Selection Trial (MOST) Kirsten E. Fleischmann,

Downstream coronary effects of drug-eluting stents

Overview of the 2012 Food and Drug Administration Circulatory System Devices Panel of the Medical Devices Advisory Committee meeting on the Edwards SAPIEN.

Quality of life and chronic heart failure therapy guided by natriuretic peptides: Results from the ProBNP Outpatient Tailored Chronic Heart Failure Therapy.

Colloquium on Therapy of Right Heart Failure

Ali Ahmed, MD, MPH, Gilbert J. Perry, MD, Jerome L. Fleg, MD, Thomas E

A critical review of hemodynamic changes and left ventricular remodeling after surgical aortic valve replacement and percutaneous aortic valve replacement

Severe Tuberculosis Sepsis in an Immunocompetent Patient

Evaluation of a novel anti-ischemic agent in acute coronary syndromes: Design and rationale for the Metabolic Efficiency with Ranolazine for Less Ischemia.

Adjunctive therapy with low-molecular-weight heparin in patients with chronic heart failure secondary to dilated cardiomyopathy: One-year follow-up results.

Outcomes in patients with heart failure with preserved, borderline, and reduced ejection fraction in the Medicare population Richard K. Cheng, MD, MS,

Rationale and design of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist Trial: A randomized, controlled study.

Impact of weight reduction on pericardial adipose tissue and cardiac structure in patients with atrial fibrillation Hany S. Abed, BPharm, MBBS, PhD,

Variation among hospitals in selection of higher-cost, “higher-tech,” implantable cardioverter-defibrillators: Data from the National Cardiovascular Data.

Rationale and design of the ATTRACT Study: A multicenter randomized trial to evaluate pharmacomechanical catheter-directed thrombolysis for the prevention.

Gender differences in adverse outcomes after contemporary percutaneous coronary intervention: An analysis from the Blue Cross Blue Shield of Michigan.

American Heart Journal

Evaluating the safety and efficacy of sodium-restricted/Dietary Approaches to Stop Hypertension diet after acute decompensated heart failure hospitalization:

Admission heart rate and in-hospital outcomes in patients hospitalized for heart failure in sinus rhythm and in atrial fibrillation Anh L. Bui, MD, Maria.

Prevalence and predictors of nonobstructive coronary artery disease identified with coronary angiography in contemporary clinical practice Manesh R.

National evaluation of adherence to β-blocker therapy for 1 year after acute myocardial infarction in patients with commercial health insurance Judith.

Differences and trends in stroke prevention anticoagulation in primary care vs cardiology specialty management of new atrial fibrillation: The Retrospective.

Single-bolus tenecteplase plus heparin compared with heparin alone for normotensive patients with acute pulmonary embolism who have evidence of right.

A multifaceted intervention to narrow the evidence-based gap in the treatment of acute coronary syndromes: Rationale and design of the Brazilian Intervention.

Rationale and design of a randomized clinical trial to assess the safety and efficacy of frequent optimization of cardiac resynchronization therapy: The.

Reasons for warfarin discontinuation in the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) Emily C. O’Brien, PhD,

Patients’ time in therapeutic range on warfarin among US patients with atrial fibrillation: Results from ORBIT-AF registry Sean D. Pokorney, MD, MBA,

Rationale and design of a randomized, double-blind, placebo-controlled trial of 6 versus 12 months clopidogrel therapy after implantation of a drug-eluting.

Inhaled nitric oxide reduces human lung allograft dysfunction

Wayne S. Dysinger, MD, MPH, James M. Pappas, MD, MBA

by Cheryl D. Bushnell, and Larry B. Goldstein

Renato D. Lopes, MD, PhD, Li Li, MS, Christopher B

Arif H. Kamal, MD, MBA, MHS, Janet H. Bull, MD, MBA, Keith M

A Pain in the Neck: Thyroid Abscess

One Appendix, Two Different Pains

Leslie R. Harrold, MD, MPH, Daniel Peterson, MS, Ashley J

Pharmacy costs of specialty medications for plaque psoriasis in the United States Eric J. Yang, BS, Kristen M. Beck, MD, Sahil Sekhon, MD, Tina Bhutani,

Irinotecan-Cisplatin Therapy for Patients with Extensive-Stage Small Cell Lung Cancer: Use Patterns among American Medical Oncologists 2000–2006 Mark.

Age and Gender Differences in Quality of Care and Outcomes for Patients with ST- segment Elevation Myocardial Infarction Sripal Bangalore, MD, MHA, Gregg.

Methylene Chloride Intoxication Treated With Hyperbaric Oxygen Therapy

Jessica L. Lee, MD, MS, Esther S. Oh, MD, Rebecca W. Lee, MD, Thomas E

Type III hyperlipoproteinemia unmasked by HIV anti-retroviral therapy

Carmelo V. Venero, MD, Paul D. Thompson, MD, Antonio B. Fernandez, MD

Hong-Tao Tie, MD, Rui Shi, MD The American Journal of Medicine

Evaluating the Probability of Previously Unknown Carriage of MRSA at Hospital Admission Stephan Harbarth, MD, MS, Hugo Sax, MD, Carolina Fankhauser-Rodriguez,

The Natural Course of Microalbuminuria among African Americans with Type 2 Diabetes: A 3-Year Study Mohamed G. Atta, MD, MPH, Kesha Baptiste-Roberts,

Validation of the Pregnancy Asthma Control Test

Daniel E. Weiner, MD, MS American Journal of Kidney Diseases

Persistent Insomnia is Associated with Mortality Risk

Sara K. Pasquali, MD, MHS, Jennifer S

Cerebrovascular Disease Incidence, Characteristics, and Outcomes in Patients Initiating Dialysis: The Choices for Healthy Outcomes in Caring for ESRD.

Volume 16, Issue 1, Pages e3-e16 (January 2019)

Usability Testing and Acceptance of an Electronic Medication Inquiry System for CKD Patients Clarissa J. Diamantidis, MD, MHS, Marni Zuckerman, MA, Wanda.

Man With Acute Eye Lesion

Niv Ad, MD, Lawrence M. Wei, MD

Primary Care Management of Skin Abscesses Guided by Ultrasound

Achieving Fairness in Access to Kidney Transplant: A Work in Progress

Postoperative medication management after surgical ablation: Clarifying the role of amiodarone therapy Hersh Maniar, MD, Eric Novak, MS The Journal.

Emily G. McDonald, MD, MSc, Ramy R. Saleh, MD, Todd C. Lee, MD, MPH

Preoperative Thienopyridine Use and Outcomes after Surgery: A Systematic Review Anita G. Au, MD, Sumit R. Majumdar, MD MPH, Finlay A. McAlister, MD MSc

Proceed with caution: The importance of surveillance in patients with pathologic complete response after chemoradiation therapy plus surgery for esophageal.

Presentation transcript:

The Adherence eValuation After Ischemic Stroke Longitudinal (AVAIL) Registry: Design, rationale, and baseline patient characteristics Cheryl Bushnell, MD, MHS, Louise Zimmer, MA, MPH, Lee Schwamm, MD, Larry B. Goldstein, MD, Nancy Clapp-Channing, MPH, Tina Harding, RN, BSN, Laura Drew, RN, BSN, Xin Zhao, MS, Eric Peterson, MD, MPH American Heart Journal Volume 157, Issue 3, Pages 428-435.e2 (March 2009) DOI: 10.1016/j.ahj.2008.11.002 Copyright © 2009 Mosby, Inc. Terms and Conditions

Figure 1 Persistence diagram. Persistence represents the duration of time from initiation to discontinuation of therapy. Patients on a medication at 1 study time point who report taking the medication at a further study time point are considered to be persistent through that period (dark green arrows). Patients for whom the timing of medication initiation is unknown, that is, begun after a study time point, are considered initiators (indicated by dotted green line). Unknown end date for medication use is indicated by a dotted red line. American Heart Journal 2009 157, 428-435.e2DOI: (10.1016/j.ahj.2008.11.002) Copyright © 2009 Mosby, Inc. Terms and Conditions